ABT-510

DRUG2 trials

Sponsors

M.D. Anderson Cancer Center, Mayo Clinic

Conditions

Head and Neck CancerMelanoma (Skin)

Phase 1

Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck Cancer

CompletedNCT00113334

M.D. Anderson Cancer CenterHead and Neck Cancer

Start: 2005-04-30End: 2008-03-31Updated: 2014-08-07

Phase 2

ABT-510 in Treating Patients With Metastatic Melanoma

CompletedNCT00602199

Mayo ClinicMelanoma (Skin)

Start: 2004-11-30End: 2005-06-30Target: 42Updated: 2011-05-16